Abstract:Ovarian carcinoma is the second most common malignant tumor of the female reproductive system and an notable cause of cancer death. The detection and diagnosis of early ovarian carcinomas are still clinical challenges, which calls for imaging studies using early ovarian carcinoma animal models. The present study aimed to optimize the 7,12-dimethylbenz(a)anthracene (DMBA)-induced model of rat ovarian tumors by investigating the delivery methods, induction dose and time of DMBA exposure, and explored the morphological features of tumors using MRI. Three schemes were performed. In scheme one the ovary was covered with absorbable hemostatic gauze loaded with a high concentration of liquid DMBA. For this scheme, 150 Sprague-Dawley rats were divided into three groups depending on the DMBA dose (1.0, 2.0 and 3.0 mg). In scheme two DMBA solution was injected under the ovarian capsule. For this scheme, 159 rats were divided into 0.5, 1.0 and 1.5 mg DMBA groups. In scheme three the ovary was covered with absorbable gauze loaded with a high concentration of solid DMBA. For this scheme 161 rats were divided into 1.0, 2.0 and 3.0 mg DMBA groups. Each group of the three schemes was further subdivided into 60-, 90-, 120-, 150- and 180-day groups. In scheme two, the tumor formation rate was 75.6% (99/131), which was the highest in the 1.5 mg group (86.4%, 38/44) and reached 100% (10/10) on day 120. The induced tumors were serous in 93.9% (93/99) of tumors. Borderline ovarian tumors accounted for 19.2% (19/99) of all tumors, and ovarian cancer accounted for 46.5% (46/99). The mean maximum diameter (MMD) of borderline ovarian tumors was 10.29±3.41 mm, and that of ovarian cancer was 15.19±7.10 mm. MMD of the solid components increased with increasing malignancy. Cystic, cystic-solid and solid tumors were observed. The ovarian subcapsular injection of 1.5 mg DMBA was the best scheme for the rat ovarian tumor model. The present model is ideal for investigating the occurrence, development and imaging of ovarian tumors.

Study of Rats' Mammary Precancer Models-Induced by DMBA Combined Estrogen and Progesterone

Establishment of Novel Rat Models for Premalignant Breast Disease.

Effect of celecoxib on hepatic and renal functions in rats with mammary carcinoma

[A Study on the Effect of Tanshinone II A Against Human Breast Cancer in Vivo].

Celecoxib in the Histological Grade of Chemically Induced Mammary Tumor in Rats

Protective and Sensitive Effects of Melatonin Combined with Adriamycin on ER+ (estrogen Receptor) Breast Cancer.

Dietary Fatty Acids Affect Lipid Metabolism and Estrogen Receptor Expression in N-Methyl-N-Nitrosourea-Induced Rat Mammary Cancer Model

Effect of Commercial and Traditional Cow Milk on Mammary Tumor

Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer

Periampullary diverticulum: an unusual cause of double duct obstruction.

Optimization of 7,12-Dimethylbenz(a)anthracene-induced Rat Epithelial Ovarian Tumors.

Curcumin Modulates Mir‐19/pten/akt/p53 Axis to Suppress Bisphenol A‐induced MCF‐7 Breast Cancer Cell Proliferation

The combined effect of pomegranate extract and tangeretin on the DMBA-induced breast cancer model

Parallel computation of electromagnetic scattering

Mangiferin Inhibits Inflammation and Cell Proliferation, and Activates Proapoptotic Events via NF-κB Inhibition in DMBA-Induced Mammary Carcinogenesis in Rats.

Betulin ameliorates 7,12‐dimethylbenz(a)anthracene‐induced rat mammary cancer by modulating MAPK and AhR/Nrf‐2 signaling pathway

Solid phase extraction-spectrophotometric determination of fluoride in water samples using magnetic iron oxide nanoparticles.

Establishment and Preliminary Observation of 7,12-Dimethylbenz[a]anthracene-induced Ovarian Tumor in Rabbits

Rat Models of Hormone Receptor-Positive Breast Cancer

DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations

Prevention and Treatment of Matrine on Hepatic Carcinoma of Rat and Its Mechanism